GAIA Bundling Analysis
GAIA Software’s Bundling Analytics tool allows facilities to examine their current practices and determine where they stand with regard to the proposed CMS Bundling regulations. There are a lot of industry concerns over the new ESRD bundling rates and this tool can help frame where individual facilities currently stand as a preliminary outlook moving forward to 2011.
The Bundling Analytics tool considers factors such as the Base Rate for bundling, the Wage Index adjustments and the current Case Mix adjustments. Once the adjusted base ESRD rate has been determined the tool uses the facility’s actual financial data to determine where it stands with respect to the proposed bundling reimbursement rate. There is a built in adjustment for inflation based upon CMS assumptions.
Key factors in determining a facility’s outlook are associated costs for EPO/ARA usage, Lab tests, IV injectible drugs and oral substitutes, and oral drugs utilization factors. CMS’s position regarding the new bundling regulations is incentivizing facilities to control the use of ESA’s, labs tests, etc. to perform well under the new regulations.
The GAIA Bundling Analytics tool is straightforward and provides structure for facilities to trend operating results over time. The calculations utilized by this tool will be updated when CMS finalizes the proposed regulations to provide a decision matrix for the available bundling options.
GAIA is making Bundling Analytics available to any organization that wants a snapshot on how bundling will affect them in each scenario, for a minimal fee. It takes approximately two weeks to prepare the preliminary report. All information is held in strict confidentiality.
Please contact us today to learn more.
